Other drugs that are currently in development for the treatment of CKD include drugs that target the renin-angiotensin-aldosterone system (RAAS), which is involved in the regulation of blood pressure and fluid balance in the body. Drugs that target the RAAS have been shown to be effective in slowing the progression of CKD in people with hypertension and diabetes.
Finally, there is a need for better awareness and education about CKD among healthcare providers and the general public. Chronic Kidney Disease Drugs Market is often asymptomatic in its early stages, which means that many people with the disease are not diagnosed until the disease has progressed to a more advanced stage. This can make it more difficult to manage and treat the disease effectively.
The Chronic Kidney Disease Drugs Market is also being driven by the development of new and innovative drugs. In recent years, several new drugs have been approved for the treatment of CKD, including drugs that target specific pathways involved in the progression of the disease. For example, sodium-glucose co-transporter 2 (SGLT2) inhibitors, which are used to treat diabetes, have been shown to have beneficial effects on kidney function in people with CKD. These drugs work by blocking the reabsorption of glucose in the kidneys, which can reduce the workload on the kidneys and slow the progression of CKD.
One of the key factors driving the growth of the CKD drugs market is the increasing prevalence of CKD worldwide. According to the National Kidney Foundation, approximately 37 million people in the United States alone have CKD, and millions more are at risk of developing the disease. CKD is also a growing problem in other parts of the world, particularly in low- and middle-income countries where access to healthcare and preventive measures is limited.
Read More:
https://knackersblogger.blogspot.com/2023/02/chronic-kidney-disease-drugs-market.html
In 2018, the global Chronic Kidney Disease Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.This report focuses on the global Chronic Kidney Disease Drugs status, future forecast, growth opportunity, key market and key players.
The study objectives are to present the Chronic Kidney Disease Drugs development in United States, Europe and China.
Report Sample includes:- Table of Contents- List of Tables & Figures- Charts- Research MethodologyGet FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-chronic-kidney-disease-drugs-2019-2025-15The key players covered in this studyKeryx Biopharmaceuticals, IncKissei Pharmaceutical Co., LtdAbbVieGlaxoSmithKlineTo know more playersMarket segment by Type, the product can be split intoACE InhibitorsCalcium Channel BlockersBeta BlockersOthersMarket segment by Application, split intoHospitalsSpecialty ClinicsMarket segment by Regions/Countries, this report coversUnited StatesEuropeChinaJapanSoutheast AsiaIndiaCentral & South AmericaThe study objectives of this report are:To analyze global Chronic Kidney Disease Drugs status, future forecast, growth opportunity, key market and key players.To present the Chronic Kidney Disease Drugs development in United States, Europe and China.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by product type, market and key regions.In this study, the years considered to estimate the market size of Chronic Kidney Disease Drugs are as follows:History Year: 2014-2018Base Year: 2018Estimated Year: 2019Forecast Year 2019 to 2025Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-chronic-kidney-disease-drugs-2019-2025-15CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/24-market-reports
Chronic kidney disease (CKD) entails a sluggish lack of functioning of kidneys.
The ordinary characteristic of kidneys is to filter and excrete wastes, and extra fluids from the blood are excreted via urine.
However, whilst a character is tormented by continual kidney sickness, kidneys can not carry out their herbal characteristic, and wastes, fluids, and electrolytes building up withinside the frame in extra amounts.
Signs and signs and symptoms of continual kidney sickness aren't obvious till kidney characteristic turns into substantially impaired.
The supportive remedy of continual kidney sickness consists of delaying the sickness development and kidney harm.
Diseases and situations together with kind 1 or kind 2 diabetes, excessive blood strain, polycystic kidney sickness, and recurrent kidney contamination end in continual kidney sickness.
